| Literature DB >> 31731764 |
Ivan Lora-Pozo1, David Lucena-Anton1, Alejandro Salazar2,3,4, Alejandro Galán-Mercant1,3, Jose A Moral-Munoz1,3.
Abstract
Abstract: This study aims to evaluate the effectiveness of high-intensity interval training compared with no intervention and other types of training interventions for people with Type 2 Diabetes. A systematic review and meta-analysis of randomized controlled trials that used high-interval intensity training to improve anthropometric, cardiopulmonary and metabolic conditions were conducted. The search was performed during October-December 2017 using the databases PubMed, Web of Science and Physiotherapy Evidence Database (PEDro). The methodological quality of the studies was evaluated using the PEDro scale. A total of 10 articles were included in this meta-analysis. After statistical analysis, favorable results were obtained for high-Intensity Interval Training compared with control (non-intervention): [Weight: Standardized mean difference (SMD) = -2.09; confidence interval (CI) 95%: (-3.41; -0.78); body-mass index: SMD = -3.73; CI 95%: (-5.53; -1.93); systolic blood pressure: SMD = -4.55; CI 95%: (-8.44; -0.65); VO2max: SMD = 12.20; CI 95%: (0.26; 24.14); HbA1c: SMD = -3.72; CI 95%: (-7.34; -0.10)], moderate intensity continuous training: [body-mass index: SMD = -0.41; CI 95%: (-0.80; -0.03); VO2max: SMD = 1.91; CI 95%: (0.18; 3.64)], and low intensity training: [Weight: SMD = -2.06; CI 95%: (-2.80; -1.31); body-mass index: SMD = -3.04; CI 95%: (-5.16; -0.92); systolic blood pressure: SMD = -2.17; CI 95%: (-3.93; -0.41); HbA1c: SMD = -1.58; CI 95%: (-1.84; -1.33)]. The results show that high-intensity interval training can be a useful strategy in order to improve anthropometric, cardiopulmonary and metabolic parameters in people with Type 2 diabetes. Despite this, it could be essential to clarify and unify criteria in the intervention protocols, being necessary new lines of research.Entities:
Keywords: high-intensity interval training; physical activity; physical exercise; type 2 diabetes
Mesh:
Year: 2019 PMID: 31731764 PMCID: PMC6887993 DOI: 10.3390/ijerph16224524
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart.
Physiotherapy Evidence Database (PEDro) scale score for clinical trials included in the review.
| PEDro Scale | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study | Total Score | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| Karstoff et al., 2013 [ | 6 | - | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Álvarez et al., 2016 [ | 6 | - | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| Terada et al., 2012 [ | 7 | - | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Mitranum et al., 2012 [ | 5 | - | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Cassidy et al., 2015 [ | 5 | - | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Ruffino et al., 2016 [ | 5 | - | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Støa et al., 2016 [ | 5 | - | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Maillard et al., 2016 [ | 5 | - | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Hollekim-Strand et al., 2014 [ | 5 | - | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Balducci et al., 2012 [ | 5 | - | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
Main characteristics of participants in the studies.
| Study | Groups | No. of Males/ | Average Age (Years) | Years after Diagnosis | Average Weight (Kg) | Average Height (cm) | Comorbidity among the Participants |
|---|---|---|---|---|---|---|---|
| Karstoff et al., 2013 [ | HIIT ( | 7/5 | 57.5 (2.4) | 3.5 (0.7) | 84.9 (4.9) | NA | None |
| LIT ( | 8/4 | 60.8 (2.2) | 6.2 (1.5) | 88.2 (4.7) | |||
| CON ( | 5/3 | 57.1 (3) | 4.5 (1.5) | 88.5 (4.7) | |||
| Álvarez et al., 2016 [ | HIIT ( | 0/13 | 45.6 (3.1) | 3.4 (1.1) | 73.8 (2) | 156 (2) | None |
| CON ( | 0/10 | 43.1 (1.5) | 3.6 (1.1) | 75.3 (1.6) | 158 (2) | ||
| Terada et al., 2012 [ | HIIT ( | 4/4 | 62 (3) | 6 (4) | 80.5 (9.9) | NA | None |
| MIT ( | 4/3 | 63 (5) | 8 (4) | 93.9 (18.3) | |||
| Mitranum et al., 2013 [ | HIIT ( | 5/9 | 61.2 (2.8) | 19.5 (0.4) | 66.5 (3.7) | 149 (4) | None |
| LIT ( | 5/9 | 61.7 (2.7) | 20.5 (0.4) | 65.8 (3.1) | 149 (5) | ||
| CON ( | 5/10 | 60.9 (2.4) | 21.1 (0.6) | 67.7 (3.2) | 152 (5) | ||
| Cassidy et al., 2015 [ | HIIT ( | 10/2 | 61 (9) | 5 (3) | 90 (15) | 171 (8) | None |
| CON ( | 8/3 | 59 (9) | 4 (2) | 90 (9) | 169 (9) | ||
| Ruffino et al., 2016 [ | HIIT ( | 16/0 | 55 (5) | 4 (4) | 96.7 (11.7) | 178 (6) | None |
| MIT ( | 97 (11.6) | 178 (6) | |||||
| Støa et al., 2016 [ | HIIT ( | 15/23 | 59 (11) | 9 (7) | 95 (15.3) | 172 (6) | None |
| MIT ( | 59 (10) | 6 (5) | 89.1 (15.6) | 170 (6) | |||
| Maillard et al., 2016 [ | HIIT ( | 0/8 | 68.2 (1.9) | 14.5 (2.1) | 79.5 (5.2) | NA | None |
| MIT ( | 0/9 | 70.1 (2.4) | 73.9 (3.4) | ||||
| Hollekim-Strand et al., 2014 [ | HIIT ( | 12/8 | 58.6 (5) | 4.2 (2.3) | NA | NA | All the patients presented diastolic dysfunction of left ventricle. |
| MIT ( | 11/6 | 54.7 (5.3) | 3 (2.6) | ||||
| Balducci et al., 2012 [ | HIIT ( | 91/61 | 59.5 (8.3) | 7.8 (6.2) | NA | NA | None |
| LIT ( | 83/53 | 58.4 (8.9) | 5.9 (4) |
HIIT—high-intensity interval training, LIT—low-intensity training, CON—control group, SD—standard deviation, NA—not available.
Main characteristics of the study interventions.
| Study | Intervention | Frequency | Session Duration | Intervention Duration | Outcome Measure | Measuring Instrument | Results |
|---|---|---|---|---|---|---|---|
| Karstoff et al., 2013 [ | G1 (HIIT): Interval walking training with 3-min repetitions at low (<70% peak energy-expenditure rate) and high (>70%) intensity. | 5 times/week | 60 min | 16 weeks | HbA1c (%); Weight and BMI; VO2max.; Systolic and Diastolic BP. | Blood sample through HPLC; DXA Scanner; Stress test. | Statistical differences were found in the LIT group: VO2max. ( |
| Álvarez et al. 2016 [ | G1 (HIIT): running/jogging (90–100% HRmax). 8–14 repetitions, active rest between sets (<70% HRmax) | 3 times/week | 22–37.5 min | 16 weeks | HbA1c (%); Systolic and diastolic BP; Weight; BMI. | Blood sample through Variant II of HPLC; OMROM | Statistical differences were found in the HIIT group: Weight ( |
| Terada et al., 2012 [ | G1 (HIIT): treadmill training or cycling intervals 1′ (100%VO2max). and 3′ (20%VO2max). | 5 times/week | 30–60 min | 12 weeks | Weight; BMI; VO2max.; % Body fat; HbA1c (%). | Stress test through treadmill and metabolic measurement system (True Max); P/H2; DXA Scanner; Blood sample. | Statistical differences were found in % Body fat ( |
| Mitranum et al., 2013 [ | G1 (HIIT): 4–6 intervals (85% VO2max) during 1 min following 4 min of active rest (50% VO2max.). | 3 times/week | 30–40 min | 12 weeks | Weight, BMI and % Body fat; VO2max.; HR; Systolic and diastolic BP. | Bioelectrical impedance; Stress test (Modified Bruce protocol); PolarTeam 2 Pro monitor; BP monitor. | Statistical differences ( |
| Cassidy et al., 2015 [ | G1 (HIIT): 3 × 3′ cycloergometry | 3 times/week | 21–31 min | 12 weeks | HbA1c (%); Weight; Systolic and diastolic BP; Heart rate. | TOSOH HLC-723G8 analyzer; Plethysmography; Vascular unloading technique. | Nonstatistical differences were found. |
| Ruffino et al. 2016 [ | G1 (HIIT): cycloergometry (86–88% HRmax). 2 sprints of 10–20′’. | 3 times/week | 10 min | 8 weeks | VO2max.; Weight and % Body fat; Systolic and diastolic BP. | TrueOne 2400 gas analysis system; DXA Scanner; Alvita MC101 Monitor. | Statistical differences ( |
| Støa et al., 2016 [ | G1 (HIIT): 4 × 4′ (85–95% HRmax) with 3′ active rest (70% HRmax). | 3 times/week | 52 min | 12 weeks | Weight; % Body fat; BMI; Systolic and diastolic BP; VO2max.; HbA1c (%). | Tefal Sensitive Computer; skin firmly; P/H2; Stethoscope and BP measurement; Stress test; Polar rs100. | Statistical differences were found in Weight ( |
| Maillard et al., 2016 [ | G1 (HIIT): cycloergometry (77–85% HRmax). | 2 times/week | 30 min | 16 weeks | Weight; BMI; % Body fat; HbA1c (%). | sRCT 709 weighing scale; P/H2; DXA Scanner; Variant II Analyzer of HPLC. | Nonstatistical differences were found. |
| Hollekim-Strand et al., 2014 [ | G1 (HIIT): 4 × 4′ (90–95% HRmax). | 3 times/week | 40 min | 12 weeks | VO2max.; HR; Systolic and diastolic BP; HbA1c (%); BMI; % Body fat. | Not showed in study. | Statistical differences were found in VO2max ( |
| Balducci et al., 2012 [ | G1 (HIIT): aerobic training (70% VO2max) + resistance training (60% 1-Repetition Maximum). | 2 times/week | 64–70 min | 48 weeks | HbA1c (%); VO2max.; BMI; Systolic and diastolic BP. | Blood biochemical test; Stress test through FitMate. | Statistical differences ( |
G—group, HIIT—high-intensity interval training, MIT—moderate-intensity training, LIT—low-intensity training, CON—control, VO2max—maximum oxygen uptake; HbA1c (%)—hemoglobin A 1c, BMI—body mass index, BP—blood pressure, HPLC—high-performance liquid chromatography, DXA—dual-energy X-ray absorptiometry, HR—heart rate.
Figure 2Forest plot for body weight. HIIT—high-intensity interval training, MIT—moderate-intensity training, LIT—low-intensity training, CI—confidence interval, IV—inverse variance, SD—standard deviation.
Figure 3Forest plot for BMI. HIIT—high-intensity interval training, MIT—moderate-intensity training, LIT—low-intensity training, CI—confidence interval, IV—inverse variance, SD—standard deviation.
Figure 4Forest plot for systolic BP. HIIT—high-intensity interval training, MIT—moderate-intensity training, LIT—low-intensity training, CI—confidence interval, IV—inverse variance, SD—standard deviation.
Figure 5Forest plot for diastolic BP. HIIT—high-intensity interval training, MIT—moderate-intensity training, LIT—low-intensity training, CI—confidence interval, IV—inverse variance, SD—standard deviation.
Figure 6Forest plot for VO2max. HIIT—high-intensity interval training, MIT—moderate-intensity training, LIT—low-intensity training, CI—confidence interval, IV—inverse variance, SD—standard deviation.
Figure 7Forest plot for HbA1c. HIIT—high-intensity interval training, MIT—moderate-intensity training, LIT—low-intensity training, CI—confidence interval, IV—inverse variance, SD—standard deviation.